In the present study, we demonstrated that ovarian cancer cells produced and secreted LPI which stimulated ECFC angiogenic potential in vitro and in vivo angiogenesis in the CAM in a GPR55-dependent manner via activation of the MAPK pathway. The gene discussed is GPR55; the disease is ovarian carcinoma.